ArticleCurrent infectious disease reports2011
Neurologic manifestations of lyme disease.
Article in Current infectious disease reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 40 citations in OpenAlex.
- Epidemiology, diagnosis and emerging therapies for Lyme disease of the Northern Hemisphere.International journal of emergency medicine · 2026Review
- Optic nerve involvement in patients with Lyme neuroborreliosis: an electrophysiological study.Documenta ophthalmologica. Advances in ophthalmology · 2024Article
- Chronic Fatigue Syndrome: A Case Report Highlighting Diagnosing and Treatment Challenges and the Possibility of Jarisch-Herxheimer Reactions If High Infectious Loads Are Present.Healthcare (Basel, Switzerland) · 2021Article
- The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020Article
- Atypical presentation of Lyme neuroborreliosis related meningitis and radiculitis.Neurology international · 2019Article
- Limitations and Confusing Aspects of Diagnostic Testing for Neurologic Lyme Disease in the United States.Journal of clinical microbiology · 2019Review
- Two cases of sarcoidosis presenting as longitudinally extensive transverse myelitis.Clinical rheumatology · 2018Review
- Texas Occurrence of Lyme Disease and Its Neurological Manifestations.Journal of neuroinfectious diseases · 2016Article
- Unilateral phrenic nerve lesion in Lyme neuroborreliosis.BMC pulmonary medicine · 2013Article
- Protracted neuroborreliosis--an unusual cause of encephalomyelitis.BMJ case reports · 2012Article
- Chronic or late lyme neuroborreliosis: analysis of evidence compared to chronic or late neurosyphilis.The open neurology journal · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Borrelia burgdorferi infection, the tick-borne spirochetosis known as Lyme disease or Lyme borreliosis, involves the nervous system (neuroborreliosis) in 10% to 15% of patients. Common manifestations include lymphocytic meningitis, cranial neuritis, mononeuropathy multiplex, and painful radiculoneuritis. Rare patients develop inflammation in the brain or spinal cord. Regardless of the form of involvement, neuroborreliosis can be microbiologically cured in virtually all patients using standard 2- to 4-week antimicrobial regimens. Oral regimens appear to be as effective as parenteral ones in most instances. Although patients ill with Lyme disease may have concomitant cognitive or memory difficulty, these symptoms are not specific to neuroborreliosis and, when present in isolation, should not be viewed as suggestive of this diagnosis. When present as part of Lyme disease, they do not require additional or different treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.